Investing Profile

Marco Boorsma

InvestorVC
General Partner at Forbion
forbion.comAmsterdam, Netherlands
Photo of Marco Boorsma, General Partner at Forbion
Your Intro Paths to Marco Boorsma

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Marco Boorsma on

cb
Current Investing Position
Forbion General Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
18

Marco Boorsma is on these Sector & Stage Rankings

Marco Boorsma's Investments On Record (10)

CompanyStageDateRound SizeTotal Raised
Orbis Medicines
SeedFeb 2024$28M
$28M
Calluna Pharma
Series AJan 2024$81M
$81M
Inversago Pharma
Series COct 2022$69M
Series BSep 2020$35M
$110M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Elizabeth Douville (Amorchem), Nanna Luneborg (Forbion)
NorthSea Therapeutics
Series CDec 2021$80M
Series BJan 2020$40M
Series ADec 2017$29M
$150M
Co-investors: Oscar Slotboom (BGV (BioGeneration Ventures)), Rob de Ree (BGV (BioGeneration Ventures)), Sander Slootweg (Forbion), Dirk Kersten (Forbion)
Rectify Pharmaceuticals
Series AOct 2021$100M
$100M
Co-investors: Jason Rhodes (Atlas Venture), David Steinberg (Longwood Fund), Jodie Morrison (Atlas Venture), Rajesh Devraj (Atlas Venture)
Inflazome
Series BNov 2018$46M
$46M
Milestone Pharmaceuticals
Series DOct 2018$80M
Series CAug 2017$55M
$290M
Co-investors: Roderick Wong (RTW Investments), Debra K. Liebert (Domain Associates), Ela Borenstein (BDC Venture Capital), Eric Linsley (Mission BioCapital)
Escalier Biosciences
Series BMar 2018$19M
$19M